rs398122973
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PP3PP5_Very_Strong
The ENST00000394308.8(ASNS):āc.1084T>Gā(p.Phe362Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,460,494 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ā ).
Frequency
Genomes: not found (cov: 32)
Exomes š: 0.0000021 ( 0 hom. )
Consequence
ASNS
ENST00000394308.8 missense
ENST00000394308.8 missense
Scores
6
11
2
Clinical Significance
Conservation
PhyloP100: 8.40
Genes affected
ASNS (HGNC:753): (asparagine synthetase (glutamine-hydrolyzing)) The protein encoded by this gene is involved in the synthesis of asparagine. This gene complements a mutation in the temperature-sensitive hamster mutant ts11, which blocks progression through the G1 phase of the cell cycle at nonpermissive temperature. Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.838
PP5
Variant 7-97855406-A-C is Pathogenic according to our data. Variant chr7-97855406-A-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 91840.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASNS | NM_001673.5 | c.1084T>G | p.Phe362Val | missense_variant | 9/13 | ENST00000394308.8 | NP_001664.3 | |
CZ1P-ASNS | NR_147989.1 | n.2713T>G | non_coding_transcript_exon_variant | 15/19 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASNS | ENST00000394308.8 | c.1084T>G | p.Phe362Val | missense_variant | 9/13 | 1 | NM_001673.5 | ENSP00000377845 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1460494Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 726550
GnomAD4 exome
AF:
AC:
3
AN:
1460494
Hom.:
Cov.:
30
AF XY:
AC XY:
0
AN XY:
726550
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Alfa
AF:
Hom.:
ExAC
AF:
AC:
1
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome Pathogenic:5
Likely pathogenic, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | May 04, 2022 | The homozygous p.Phe362Val variant in ASNS was identified by our study in 1 individual with asparagine synthetase deficiency. The variant has been reported in 4 Iranian Jewish individuals with asparagine synthetase deficiency (PMID: 24139043), segregated with disease in 2 affected relatives from 2 families (PMID: 24139043), but was absent from large population studies. This variant has also been reported in ClinVar (Variation ID: 91840) as pathogenic by Invitae and OMIM, and as likely pathogenic by CeGaT Praxis fuer Humangenetik Tuebingen. In vitro functional studies provide some evidence that the p.Phe362Val variant may impact protein function (PMID: 24139043). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. The presence of this variant in 5 affected homozygotes, and in 5 individuals with asparagine synthetase deficiency increases the likelihood that the p.Phe362Val variant is pathogenic (PMID: 24139043). In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic. ACMG/AMP Criteria applied: PM2, PM3, PP1_moderate, PS3_moderate (Richards 2015). - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jun 17, 2022 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 16, 2013 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 18, 2022 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 15, 2023 | This sequence change replaces phenylalanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 362 of the ASNS protein (p.Phe362Val). This variant is present in population databases (rs398122973, gnomAD 0.0009%). This missense change has been observed in individuals with asparagine synthetase deficiency (PMID: 24139043). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 91840). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on ASNS protein function. Experimental studies have shown that this missense change affects ASNS function (PMID: 24139043). For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
D;D;.;D;.;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;.;.;.;.;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;.;M;.;.;.
MutationTaster
Benign
D;D;D;D;D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D;D;D;D;D;D
REVEL
Uncertain
Sift
Uncertain
D;D;D;D;D;D;D
Sift4G
Uncertain
T;T;D;T;T;D;T
Polyphen
P;P;.;P;.;.;.
Vest4
MutPred
Gain of disorder (P = 0.1167);Gain of disorder (P = 0.1167);.;Gain of disorder (P = 0.1167);.;.;.;
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at